Mid-Ohio Oncology/Hematology, Inc. Dba

Columbus, Ohio 43219

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Metastasis, Prostatic Neoplasms, Stage III (Unresectable) or Stage IV Advanced Melanoma, Transitional Cell Carcinoma

Studies at this site

• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• Expanded Access Program With Nivolumab to Treat Melanoma — NO_LONGER_AVAILABLE
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed